190 related articles for article (PubMed ID: 30063470)
1. Hematopoietic stem-cell transplantation in systemic sclerosis: an update.
Spierings J; van Rhijn-Brouwer FCC; van Laar JM
Curr Opin Rheumatol; 2018 Nov; 30(6):541-547. PubMed ID: 30063470
[TBL] [Abstract][Full Text] [Related]
2. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
Burt RK; Milanetti F
Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
[TBL] [Abstract][Full Text] [Related]
5. [Autologous stem cell transplantation in systemic sclerosis].
Henes JC; Wirths S; Kötter I
Z Rheumatol; 2016 Oct; 75(8):762-769. PubMed ID: 27510996
[TBL] [Abstract][Full Text] [Related]
6. Update on stem cell transplantation for systemic sclerosis: recent trial results.
Naraghi K; van Laar JM
Curr Rheumatol Rep; 2013 May; 15(5):326. PubMed ID: 23516015
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience.
Henrique-Neto Á; Vasconcelos MYK; Dias JBE; de Moraes DA; Gonçalves MS; Zanin-Silva DC; Zucoloto TG; de Oliveira MFC; Dotoli GM; Weffort LF; Leopoldo VC; Oliveira MC
Adv Rheumatol; 2021 Feb; 61(1):9. PubMed ID: 33549135
[TBL] [Abstract][Full Text] [Related]
8. Stem cell transplantation in systemic sclerosis.
van Laar JM; Sullivan K
Curr Opin Rheumatol; 2013 Nov; 25(6):719-25. PubMed ID: 24047607
[TBL] [Abstract][Full Text] [Related]
9. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
[TBL] [Abstract][Full Text] [Related]
10. Autologous hematopoietic stem cell transplantation for systemic sclerosis.
Milanetti F; Bucha J; Testori A; Burt RK
Curr Stem Cell Res Ther; 2011 Mar; 6(1):16-28. PubMed ID: 20955159
[TBL] [Abstract][Full Text] [Related]
11. Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures.
Assassi S; Wang X; Chen G; Goldmuntz E; Keyes-Elstein L; Ying J; Wallace PK; Turner J; Zheng WJ; Pascual V; Varga J; Hinchcliff ME; Bellocchi C; McSweeney P; Furst DE; Nash RA; Crofford LJ; Welch B; Pinckney A; Mayes MD; Sullivan KM
Ann Rheum Dis; 2019 Oct; 78(10):1371-1378. PubMed ID: 31391177
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature.
Eyraud A; Scouppe L; Barnetche T; Forcade E; Lazaro E; Duffau P; Richez C; Seneschal J; Truchetet ME;
Br J Dermatol; 2018 Mar; 178(3):650-658. PubMed ID: 28906550
[TBL] [Abstract][Full Text] [Related]
14. Autologous Hematological Stem Cell Transplantation for Systemic Sclerosis in Israel.
Rimar D; Butbul Aviel Y; Gefen A; Nevo N; Shen-Orr SS; Starosvetsky E; Rosner I; Rozenbaum M; Kaly L; Boulman N; Slobodin G; Zuckerman T
Isr Med Assoc J; 2020 Feb; 22(2):104-110. PubMed ID: 32043328
[TBL] [Abstract][Full Text] [Related]
15. Autologous haematopoietic stem cell transplantation for Japanese patients with systemic sclerosis: Long-term follow-up on a phase II trial and treatment-related fatal cardiomyopathy.
Nakamura H; Odani T; Yasuda S; Noguchi A; Fujieda Y; Kato M; Oku K; Bohgaki T; Sugita J; Endo T; Teshima T; Atsumi T
Mod Rheumatol; 2018 Sep; 28(5):879-884. PubMed ID: 29251023
[TBL] [Abstract][Full Text] [Related]
16. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis.
Burt RK; Oliveira MC; Shah SJ; Moraes DA; Simoes B; Gheorghiade M; Schroeder J; Ruderman E; Farge D; Chai ZJ; Marjanovic Z; Jain S; Morgan A; Milanetti F; Han X; Jovanovic B; Helenowski IB; Voltarelli J
Lancet; 2013 Mar; 381(9872):1116-24. PubMed ID: 23363664
[TBL] [Abstract][Full Text] [Related]
17. Stem cell transplant in systemic sclerosis: An Indian experience.
Nair V; Vasdev V; Kumar A; Shankar S; Nair V; Sharma A
Int J Rheum Dis; 2018 Apr; 21(4):859-865. PubMed ID: 29392863
[TBL] [Abstract][Full Text] [Related]
18. Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registry.
Blank N; Schmalzing M; Moinzadeh P; Oberste M; Siegert E; Müller-Ladner U; Riemekasten G; Günther C; Kötter I; Zeidler G; Pfeiffer C; Juche A; Jandova I; Ehrchen J; Susok L; Schmeiser T; Sunderkötter C; Distler JHW; Worm M; Kreuter A; Keyßer G; Lorenz HM; Krieg T; Hunzelmann N; Henes J;
Arthritis Res Ther; 2022 Nov; 24(1):258. PubMed ID: 36424638
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in systemic sclerosis before and after autologous haematopoietic stem cell transplant-a systematic review.
Puyade M; Maltez N; Lansiaux P; Pugnet G; Roblot P; Colmegna I; Hudson M; Farge D
Rheumatology (Oxford); 2020 Apr; 59(4):779-789. PubMed ID: 31504944
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens.
Oyama Y; Traynor AE; Barr W; Burt RK
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S81-3. PubMed ID: 12931250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
